Notice of Annual General Meeting/Proxy Form
Released
Released
Announcement PDF
PRAIRIE LITHIUM LIMITED
ACN 008 720 223
NOTICE OF ANNUAL GENERAL MEETING
Notice is given that the Meeting will be held at:
TIME: 10:00am WST
DATE: 27 November 2026
PLACE: Level 2, 10 Outram Street, West Perth WA 6005
The business of the Meeting affects your shareholding and your vote is important.
This Notice should be read in its entirety. If Shareholders are in doubt as to how they should vote,
they should seek advice from their professional advisers prior to voting.
The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Regulations 2001
(Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at
10:00am (WST) on 25 November 2026.
1
B U S I N E S S OF TH E M E E T I N G
FINANCIAL STATEMENTS AND REPORTS
To receive and consider the annual financial report of the Company for the financial year ended
30 June 2026 together with the declaration of the Directors, the Directors’ report, the Remuneration
Report and the auditor’s report.
1. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as a non-binding resolution:
“That, for the purposes of section 250R(2) of the Corporations Act and for all other
purposes, approval is given for the adoption of the Remuneration Report as
contained in the Company’s annual financial report for the financial year ended 30
June 2026.”
Note: the vote on this Resolution is advisory only and does not bind the Directors or the Company.
2. RESOLUTION 2 – RE-ELECTION OF DIRECTOR – MR ZACHARY MAURER
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purpose of clause 15.2 of the Constitution, Listing Rule 14.4 and for all
other purposes, Zachary Maurer, a Director, retires by rotation, and being eligible, is
re-elected as a Director.”
3. RESOLUTION 3 – RE-ELECTION OF DIRECTOR – MR LAVERN LUND
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purpose of clause 15.2 of the Constitution and for all other purposes,
Lavern Lund, a Director, retires by rotation, and being eligible, is re-elected as a
Director.”
4. RESOLUTION 4 – RATIFICATION OF AUGUST 2026 ISSUE OF SHARES TO ACUITY CAPITAL UNDER
THE AT-THE-MARKET SUBSCRIPTION AGREEMENT
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“That, for the purposes of Listing Rule 7.4 and for all other purposes, Shareholders
ratify the issue of 200,000,000 Shares to Acuity Capital on 14 August 2026 on the terms
and conditions set out in the Explanatory Statement.”
5. RESOLUTION 5 – APPROVAL OF 7.1A MANDATE
To consider and, if thought fit, to pass the following resolution as a special resolution:
“That, for the purposes of Listing Rule 7.1A and for all other purposes, approval is
given for the Company to issue up to that number of Equity Securities equal to 10%
of the issued capital of the Company at the time of issue, calculated in accordance
with the formula prescribed in Listing Rule 7.1A.2 and otherwise on the terms and
conditions set out in the Explanatory Statement.”
Dated: 26 October 2026
2
Voting Prohibition Statements
Resolution 1 – Adoption of
Remuneration Report
In accordance with sections 250BD(2) and 250R, a vote on this Resolution must
not be cast:
(a) by or on behalf of a member of the Key Management Personnel,
details of whose remuneration are included in the Remuneration
Report or a Closely Related Party of such a member, regardless of the
capacity in which the vote is cast; or
(b) as a proxy by a member of the Key Management Personnel at the
date of the Meeting, or their Closely Related Parties.
However, a person (the voter) described above may cast a vote on this
Resolution as a proxy if the vote is not cast on behalf of a person described
above and either:
(a) the voter is appointed as a proxy by writing that specifies the way the
proxy is to vote on this Resolution; or
(b) the voter is the Chair and the appointment of the Chair as proxy:
(i) does not specify the way the proxy is to vote on this
Resolution; and
(ii) expressly authorises the Chair to exercise the proxy even
though this Resolution is connected directly or indirectly
with the remuneration of a member of the Key
Management Personnel.
Voting Exclusion Statements
In accordance with Listing Rule 14.11, the Company will disregard any votes cast in favour of the
Resolution set out below by or on behalf of the following persons:
Resolution 4 – Ratification of
August 2026 issue of Shares to
Acuity Capital under the At-the-
Market Subscription Agreement
Acuity Capital or any other person who participated in the issue or an associate
of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as a proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with the directions given to the proxy or attorney to vote on the Resolution in
that way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair
decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf
of a beneficiary provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is
not excluded from voting, and is not an associate of a person excluded from
voting, on the Resolution; and
(ii) the holder votes on the Resolution in accordance with directions given by the
beneficiary to the holder to vote in that way.
3
Voting by proxy
To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in
accordance with the instructions set out on the Proxy Form.
In accordance with section 249L of the Corporations Act, Shareholders are advised that:
• each Shareholder has a right to appoint a proxy;
• the proxy need not be a Shareholder of the Company; and
• a Shareholder who is entitled to cast two or more votes may appoint two proxies and may
specify the proportion or number of votes each proxy is appointed to exercise. If the
Shareholder appoints two proxies and the appointment does not specify the proportion or
number of the member’s votes, then in accordance with section 249X(3) of the
Corporations Act, each proxy may exercise one-half of the votes.
Shareholders and their proxies should be aware that:
• if proxy holders vote, they must cast all directed proxies as directed; and
• any directed proxies which are not voted will automatically default to the Chair, who must
vote the proxies as directed.
Voting in person
To vote in person, attend the Meeting at the time, date and place set out above.
Should you wish to discuss the matters in this Notice please do not hesitate to contact the Company
Secretary on +61 8 6313 3936.
4
E X PL A N A T O R Y S T A T E M E N T
This Explanatory Statement has been prepared to provide information which the Directors believe
to be material to Shareholders in deciding whether or not to pass the Resolutions.
1. FINANCIAL STATEMENTS AND REPORTS
In accordance with the Corporations Act, the business of the Meeting will include receipt
and consideration of the annual financial report of the Company for the financial year
ended 30 June 2026 together with the declaration of the Directors, the Directors’ report,
the Remuneration Report and the auditor’s report.
The Company will not provide a hard copy of the Company’s annual financial report to
Shareholders unless specifically requested to do so. The Company’s annual financial report
is available on its website at www.prairielithium.com.
2. RESOLUTION 1 – ADOPTION OF REMUNERATION REPORT
2.1 General
The Corporations Act requires that at a listed company’s annual general meeting, a
resolution that the remuneration report be adopted must be put to the shareholders.
However, such a resolution is advisory only and does not bind the company or the directors
of the company.
The remuneration report sets out the company’s remuneration arrangements for the
directors and senior management of the company. The remuneration report is part of the
directors’ report contained in the annual financial report of the company for a financial
year.
The chair of the meeting must allow a reasonable opportunity for its shareholders to ask
questions about or make comments on the remuneration report at the annual general
meeting.
2.2 Voting consequences
A company is required to put to its shareholders a resolution proposing the calling of
another meeting of shareholders to consider the appointment of directors of the company
(Spill Resolution) if, at consecutive annual general meetings, at least 25% of the votes cast
on a remuneration report resolution are voted against adoption of the remuneration report
and at the first of those annual general meetings a Spill Resolution was not put to vote. If
required, the Spill Resolution must be put to vote at the second of those annual general
meetings.
If more than 50% of votes cast are in favour of the Spill Resolution, the company must
convene a shareholder meeting (Spill Meeting) within 90 days of the second annual
general meeting.
All of the directors of the company who were in office when the directors' report (as
included in the company’s annual financial report for the most recent financial year) was
approved, other than the managing director of the company, will cease to hold office
immediately before the end of the Spill Meeting but may stand for re-election at the Spill
Meeting.
Following the Spill Meeting those persons whose election or re-election as directors of the
company is approved will be the directors of the company.
2.3 Previous voting results
At the Company’s previous annual general meeting held on 10 November 2025, the votes
cast against the remuneration report considered at that annual general meeting were less
than 25%. Accordingly, the Spill Resolution is not relevant for this Meeting.
5
3. RESOLUTION 2 – RE-ELECTION OF DIRECTOR – MR ZACHARY MAURER
3.1 General
Listing Rule 14.4 and clause 15.2 of the Constitution provide that a Director (other than a
managing director) must not hold office without re-election past the third annual general
meeting following the Director’s appointment or three years, whichever is the longer.
Mr Maurer, who was last elected as a Director on 28 November 2023 and has held office
without re-election since that date, retires by rotation in accordance with Listing Rule 14.4
and clause 15.2 of the Constitution and, being eligible, seeks re-election.
Further information in relation to Mr Maurer is set out below.
Qualifications,
experience and other
material directorships
Mr Maurer has 15 years of experience in North America’s
energy sector. In 2019, he founded and incorporated Prairie
Lithium. As President & CEO of Prairie Lithium, he led multiple
rounds of private equity funding while advancing lithium
extraction technology and brine resource exploration in
Saskatchewan, Canada. In 2023, Prairie Lithium was acquired
by Arizona Lithium (now Prairie Lithium Limited).
In recognition for his contributions to Canada, he was awarded
the Queen Elizabeth II Platinum Jubilee Medal. He holds a B.Sc.
in Geology from the University of Regina and a Diploma in
Exploration Information Technology from the South Alberta
Institute of Technology (SAIT).
Mr Maurer does not currently hold, and has not in the past three
years held, any other directorships of listed companies.
Term of office Mr Maurer has served as a Director since 24 March 2023 and
was last elected as a Director on 28 November 2023.
Independence If re-elected, the Board does not consider that Mr Maurer will
be an independent Director due to his employment by the
Company in an executive capacity.
Board
recommendation
Having received an acknowledgement from Mr Maurer that he
will have sufficient time to fulfil his responsibilities as a Director
and having reviewed the performance of Mr Maurer since his
appointment to the Board and the skills, knowledge,
experience and capabilities required by the Board, the
Directors (other than Mr Maurer) recommend that Shareholders
vote in favour of this Resolution.
3.2 Technical information required by Listing Rule 14.1A
If this Resolution is passed, Mr Maurer will be re-elected to the Board as an Executive
Director.
If this Resolution is not passed, Mr Maurer will not continue in his role as an Executive
Director. The Company may seek nominations or otherwise identify suitably qualified
candidates to join the Board. As an additional consequence, this may detract from the
Board’s and the Company’s ability to execute on its strategic vision.
4. RESOLUTION 3 – RE-ELECTION OF DIRECTOR – MR LAVERN LUND
4.1 General
The Constitution sets out the requirements for determining which Directors are to retire by
rotation at an annual general meeting.
Mr Lund, who was elected on 30 April 2024 and has served as a Director since 5 June 2024,
being eligible retires by rotation and seeks re-election.
Further information in relation to Mr Lund is set out below.
6
Qualifications,
experience and other
material directorships
Mr Lund is the CEO of Navajo Transitional Energy Company, a
tribally owned entity and the 3rd largest coal mining company
in the U.S with operations in the Navajo Nation, Wyoming, and
Montana.
Mr. Lund is a seasoned mining executive with 30 years of
experience in operational management, business
development, and new project development with extensive
field experience at multiple mining operations, including two
large greenfield mining projects. He holds a B.S. in Civil
Engineering from North Dakota State University, an MBA from
Auburn University, a graduate of Wharton’s Advanced
Management Program and a retired professional engineer.
Mr Lund was a director of Texas Mineral Resources Corp
(OTCQB: TMRC) from May 2022 to January 2025 and does not
currently hold, and has not otherwise in the past three years
held, any other directorships of listed companies.
Term of office Mr Lund was elected as a Director on 30 April 2024 and has
served as a Director since 5 June 2024.
Independence Mr Lund has no interests, position or relationship that might
influence, or reasonably be perceived to influence, in a
material respect his capacity to bring an independent
judgement to bear on issues before the Board and to act in the
best interest of the Company as a whole rather than in the
interests of an individual security holder or other party.
If re-elected the Board considers Mr Lund will be an
independent Director.
Board
recommendation
Having received an acknowledgement from Mr Lund that he
will have sufficient time to fulfil his responsibilities as a Director
and having reviewed the performance of Mr Lund since his
appointment to the Board and the skills, knowledge,
experience and capabilities required by the Board, the
Directors (other than Mr Lund) recommend that Shareholders
vote in favour of this Resolution.
4.2 Technical information required by Listing Rule 14.1A
If this Resolution is passed, Mr Lund will be re-elected to the Board as an independent Non-
Executive Director.
If this Resolution is not passed, Mr Lund will not continue in his role as an independent Non-
Executive Director. The Company may seek nominations or otherwise identify suitably
qualified candidates to join the Board. As an additional consequence, this may detract
from the Board’s and the Company’s ability to execute on its strategic vision.
5. BACKGROUND TO RESOLUTION 4 – ACUITY CAPITAL FACILITY
5.1 Facility
On 3 May 2024, the Company (then named Arizona Lithium Limited) announced that it
had entered into an At-the-Market Subscription Agreement with Acuity Capital Investment
Management Pty Ltd ATF Acuity Capital Holdings Trust (Acuity Capital) (ATM Agreement).
Under the ATM Agreement, Acuity Capital has agreed to provide the Company with a
facility of up to $10,000,000 of standby equity capital until 31 January 2029 (Facility).
A summary of the ATM Agreement is set out below:
Subscription The Company retains full control of all aspects of the subscription
process, having sole discretion as to whether or not to utilise the ATM
Agreement, the maximum number of Shares to be issued, the minimum
issue price of Shares and the timing of each subscription (if any). There
7
is no requirement for the Company to utilise the ATM Agreement and
the Company may terminate the ATM Agreement at any time, on 5
business days’ notice and without cost or penalty. Acuity Capital and
the ATM Agreement do not place any restrictions at any time on the
Company raising capital through other methods.
Term 5 April 2024 - 31 January 2029 (4 years 9 months)
Establishment Fee $25,000
Facility Limit $10,000,000
Collateral 200,000,000 Shares, issued to Acuity Capital for nil cash consideration as
security for the Company’s obligations under the ATM Agreement
(Collateral Shares). Acuity Capital may only deal with the Collateral
Shares as permitted by the ATM Agreement.
If the Company does not issue the Shares the subject of a drawdown
after Acuity Capital has paid the subscription amount, or if the
Company and Acuity Capital otherwise agree, the Company’s
obligation to issue those Shares may be satisfied by Acuity Capital
retaining an equivalent number of Collateral Shares at the issue price
for that drawdown. Collateral Shares applied in this way are not
required to be returned to the Company, and the Company may issue
equivalent collateral shares to Acuity Capital on the same terms to
replace them.
Expiry: any Collateral Shares not applied by set-off at the expiry or earlier
termination of the ATM Agreement must be bought back by the
Company and cancelled for nil consideration (subject to Shareholder
approval).
Further details relating to the ATM Agreement are set out in the Company’s
announcement of 3 May 2024 and the Company’s notice of annual general meeting
released to ASX on 25 October 2024.
In accordance with the ATM Agreement, the Company issued 200,000,000 Collateral
Shares to Acuity Capital on 3 May 2024.
5.2 August 2026 Issue
On 20 May 2026, the Company announced that it had raised $1,420,000 (inclusive of costs)
under the Facility at a deemed issue price of $0.0071 per Share (being a premium to the
15-day volume weighted average price of Shares to 19 May 2026) (May 2026 Drawdown).
In accordance with the set-off mechanism under the ATM Agreement described in Section
5.1, the Company's obligation to issue 200,000,000 Shares under the May 2026 Drawdown
was satisfied by Acuity Capital retaining the 200,000,000 Collateral Shares it held at that
issue price. No new Shares were issued under the May 2026 Drawdown and Acuity Capital
is not required to return those Collateral Shares to the Company.
On 14 August 2026, the Company issued 200,000,000 new Shares to Acuity Capital for nil
cash consideration as equivalent collateral shares under the ATM Agreement, to replace
the Collateral Shares applied under the May 2026 Drawdown (Replacement Collateral
Shares). The Replacement Collateral Shares were issued using the Company's existing
placement capacity under Listing Rule 7.1 and are held by Acuity Capital as security on
the same terms as the Collateral Shares described in Section 5.1.
Ratification of the issue of the Replacement Collateral Shares (August 2026 Issue) is sought
under Resolution 4.
5.3 Use of funds
The funds raised under the May 2026 Drawdown have been applied towards the
construction of the Company's first commercial production facility at Pad 1 at the Prairie
Lithium Project.
8
6. RESOLUTION 4 – RATIFICATION OF AUGUST 2026 ISSUE OF SHARES TO ACUITY CAPITAL UNDER
THE AT-THE-MARKET SUBSCRIPTION AGREEMENT
6.1 General
A summary of the Facility and the issue of the Replacement Collateral Shares is set out in
Sections 5.1 and 5.2 above.
This Resolution seeks Shareholder ratification for the purposes of Listing Rule 7.4 for the issue
of 200,000,000 Replacement Collateral Shares to Acuity Capital on 14 August 2026 for nil
cash consideration as security for the Facility.
6.2 Listing Rule 7.1
Broadly speaking, and subject to a number of exceptions, Listing Rule 7.1 limits the amount
of equity securities that a listed company can issue without the approval of its shareholders
over any 12 month period to 15% of the fully paid ordinary shares it had on issue at the start
of that period.
The issue does not fit within any of the exceptions set out in Listing Rule 7.2 and, as it has
not yet been approved by Shareholders, it effectively uses up part of the 15% limit in Listing
Rule 7.1, reducing the Company’s capacity to issue further equity securities without
Shareholder approval under Listing Rule 7.1 for the 12 month period following the date of
the issue.
6.3 Listing Rule 7.4
Listing Rule 7.4 allows the shareholders of a listed company to approve an issue of equity
securities after it has been made or agreed to be made. If they do, the issue is taken to
have been approved under Listing Rule 7.1 and so does not reduce the company’s
capacity to issue further equity securities without shareholder approval under that rule.
The Company wishes to retain as much flexibility as possible to issue additional equity
securities in the future without having to obtain Shareholder approval for such issues under
Listing Rule 7.1. Accordingly, the Company is seeking Shareholder ratification pursuant to
Listing Rule 7.4 for the issue.
6.4 Technical information required by Listing Rule 14.1A
If this Resolution is passed, the issue will be excluded in calculating the Company’s 15% limit
in Listing Rule 7.1, effectively increasing the number of equity securities the Company can
issue without Shareholder approval over the 12 month period following the date of the
issue.
If this Resolution is not passed, the issue will be included in calculating the Company’s 15%
limit in Listing Rule 7.1, effectively decreasing the number of equity securities that the
Company can issue without Shareholder approval over the 12 month period following the
date of the issue.
6.5 Technical information required by Listing Rules 7.4 and 7.5
REQUIRED INFORMATION DETAILS
Names of persons to
whom Securities were
issued or the basis on
which those persons
were identified/selected
Acuity Capital, being the counterparty to the ATM
Agreement. Acuity Capital is not a related party of the
Company.
Number and class of
Securities issued
200,000,000 Shares were issued.
Terms of Securities The Shares were fully paid ordinary shares in the capital of
the Company issued on the same terms and conditions as
the Company’s existing Shares.
9
REQUIRED INFORMATION DETAILS
Date(s) on or by which
the Securities were
issued
14 August 2026.
Price or other
consideration the
Company received for
the Securities
The Replacement Collateral Shares were issued for nil cash
consideration as security under the ATM Agreement. Refer
to Sections 5.1 and 5.2.
Purpose of the issue,
including the intended
use of any funds raised
by the issue
The purpose of the issue was to provide security to Acuity
Capital under the ATM Agreement. No funds were raised by
the issue.
Summary of material
terms of agreement to
issue
The Replacement Collateral Shares were issued under the
ATM Agreement, a summary of the material terms of which
is set out in Section 5.1.
Voting exclusion
statement
A voting exclusion statement applies to this Resolution.
Compliance The issue did not breach Listing Rule 7.1.
7. RESOLUTION 5 – APPROVAL OF 7.1A MANDATE
7.1 General
This Resolution seeks Shareholder approval by way of special resolution for the Company
to have the additional 10% placement capacity provided for in Listing Rule 7.1A to issue
Equity Securities without Shareholder approval.
A summary of Listing Rule 7.1 is set out in Section 6.2 above.
Under Listing Rule 7.1A, an Eligible Entity may seek shareholder approval by way of a
special resolution passed at its annual general meeting to increase this 15% limit by an
extra 10% to 25% (7.1A Mandate). An Eligible Entity means an entity which is not included
in the S&P/ASX 300 Index and has a market capitalisation of $300,000,000 or less. As at the
date of this Notice, the Company’s market capitalisation is approximately $34,681,887. The
Company is therefore an Eligible Entity.
7.2 Technical information required by Listing Rule 14.1A
For this Resolution to be passed, at least 75% of votes cast by Shareholders present and
eligible to vote at the Meeting must be cast in favour of the Resolution.
If this Resolution is passed, the Company will be able to issue Equity Securities up to the
combined 25% limit in Listing Rules 7.1 and 7.1A without any further Shareholder approval.
If this Resolution is not passed, the Company will not be able to access the additional 10%
capacity to issue Equity Securities without Shareholder approval under Listing Rule 7.1A
and will remain subject to the 15% limit on issuing Equity Securities without Shareholder
approval set out in Listing Rule 7.1.
7.3 Technical information required by Listing Rule 7.3A
REQUIRED
INFORMATION
DETAILS
Period for which the
7.1A Mandate is valid
The 7.1A Mandate will commence on the date of the Meeting
and expire on the first to occur of the following:
(a) the date that is 12 months after the date of this
Meeting;
10
REQUIRED
INFORMATION
DETAILS
(b) the time and date of the Company’s next annual
general meeting; and
(c) the time and date of approval by Shareholders of
any transaction under Listing Rule 11.1.2 (a
significant change in the nature or scale of
activities) or Listing Rule 11.2 (disposal of the main
undertaking).
Minimum price Any Equity Securities issued under the 7.1A Mandate must be
in an existing quoted class of Equity Securities and be issued
for cash consideration at a minimum price of 75% of the
volume weighted average price of Equity Securities in that
class, calculated over the 15 trading days on which trades in
that class were recorded immediately before:
(a) the date on which the price at which the Equity
Securities are to be issued is agreed by the entity
and the recipient of the Equity Securities; or
(b) if the Equity Securities are not issued within 10 trading
days of the date in paragraph (a) above, the date
on which the Equity Securities are issued.
Use of funds The Company intends to use funds raised from issues of Equity
Securities under the 7.1A Mandate for the construction,
commissioning and operation of the Company’s first
commercial production facility at the Prairie Lithium Project in
Saskatchewan, Canada, the further development of the
Company’s projects, the potential acquisition of new assets
or investments (including expenses associated with any such
acquisition) and for general working capital.
Risk of economic and
voting dilution
Any issue of Equity Securities under the 7.1A Mandate will
dilute the interests of Shareholders who do not receive any
Shares under the issue.
If this Resolution is approved by Shareholders and the
Company issues the maximum number of Equity Securities
available under the 7.1A Mandate, the economic and voting
dilution of existing Shares would be as shown in the table
below.
The table below shows the dilution of existing Shareholders
calculated in accordance with the formula outlined in Listing
Rule 7.1A.2, on the basis of the closing market price of Shares
and the number of Equity Securities on issue as at 20 October
2026.
The table also shows the voting dilution impact where the
number of Shares on issue (Variable A in the formula) changes
and the economic dilution where there are changes in the
issue price of Shares issued under the 7.1A Mandate.
DILUTION
Number of Shares on
Issue (Variable A in
Listing Rule 7.1A.2)
Shares issued
– 10% voting
dilution
Issue Price
$0.003 $0.006 $0.009
50%
decrease
Issue Price
50%
increase
Funds Raised
11
REQUIRED
INFORMATION
DETAILS
Current 5,780,314,
445 Shares
578,031,444
Shares
$1,734,094 $3,468,188 $5,202,282
50%
increase
8,670,471,
668 Shares
867,047,166
Shares
$2,601,141 $5,202,282 $7,803,424
100%
increase
11,560,628
,890
Shares
1,156,062,889
Shares
$3,468,188 $6,936,377 $10,404,566
*The number of Shares on issue (Variable A in the formula) could increase
as a result of the issue of Shares that do not require Shareholder approval
(such as under a pro-rata rights issue or scrip issued under a takeover
offer) or that are issued with Shareholder approval under Listing Rule 7.1.
The table above uses the following assumptions:
1. There are currently 5,780,314,445 Shares on issue.
2. The issue price set out above is the closing market price of the
Shares on the ASX on 20 October 2026 (being $0.006) (Issue Price).
The Issue Price at a 50% increase and 50% decrease are each
rounded to three decimal places prior to the calculation of the
funds raised.
3. The Company issues the maximum possible number of Equity
Securities under the 7.1A Mandate.
4. The Company has not issued any Equity Securities in the 12 months
prior to the Meeting that were not issued under an exception in
Listing Rule 7.2 or with approval under Listing Rule 7.1 (which, if
Resolution 4 is passed, will include the Shares the subject of that
Resolution).
5. The issue of Equity Securities under the 7.1A Mandate consists only
of Shares. It is assumed that no Options are exercised into Shares
before the date of issue of the Equity Securities. If the issue of Equity
Securities includes quoted Options, it is assumed that those quoted
Options are exercised into Shares for the purpose of calculating the
voting dilution effect on existing Shareholders.
6. The calculations above do not show the dilution that any one
particular Shareholder will be subject to. All Shareholders should
Share your feedback
Discover